IMPDIndianapolis Metropolitan Police Department (Indianapolis, Indiana)
IMPDInvestigational Medicinal Product Dossier
IMPDInosine Monophosphate Dehydrogenase
IMPDInstitute for Multi-Party Democracy
IMPDInstitute of Malaria and Parasitic Diseases (Kabul, Afghanistan)
IMPDInteroperability Montana Project Directors
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
Looking forward, we are working to submit an IMPD for BeneCeed as a starting point for product approvals, and in doing so, we hope to advance this first product candidate through the clinic to hopefully become one of the only approved cannabinoid medicinal products.
When the talks about the wellness initiative were begun, one of the first partners to sign on was IMPD, which will be among law enforcement agencies putting officers in schools to work with students.
V(t) and [xi](t) are, respectively, the vaccination and antiviral treatment controls and [[rho].sub.D]([t.sub.i])D([t.sub.i]) is the impulsive action of removal of corpses (or "culling") for all [t.sub.i] [member of] ImpD with some piecewise continuous [[rho].sub.D](t) [member of] [0, 1].
Currently PET clinical studies with radiolabelled NMEs are considered a clinical trial by the MHRA, requiring submission of an IMPD in the Uk.
Aastrom says initiation of the trial followed the Diabetes Center's receipt of the licenses and the Investigational Medicinal Product Dossier (IMPD) necessary to manufacture and use cells for clinical trials in compliance with the new European Union directives.
Other missiles developed and successfully test-fired under the IMPD include the "Prithvi" (Earth) surface-to-surface missile, the "Agni" (Fire) intermediate-range ballistic missile, the "Akash" (Sky) multi-target surface-to-air missile and the "Nag" (cobra) antitank guided missile.
Indianapolis Animal Care Services did their job and got an IMPD officer on the scene within minutes.
InflaRx announced the approval of an investigational medicinal product dossier, or IMPD, from the European regulatory authorities, allowing InflaRx to initiate a phase II study with IFX-1, an anti-human complement factor C5a antibody, in patients with ANCA-associated vasculitis.
In the US, Protalex has open INDs for the treatment of RA and ITP and in Europe, an open IMPD for ITP.
This needs to be done in advance of a formal submission of an investigational new drug file (IND), or an investigational medicinal product dossier (IMPD) to an authority.